(0.28%) 5 145.75 points
(0.30%) 38 555 points
(0.37%) 17 911 points
(-0.82%) $83.16
(1.35%) $1.949
(-0.14%) $2 343.90
(0.18%) $27.59
(0.86%) $930.00
(-0.29%) $0.932
(-0.46%) $10.97
(-0.39%) $0.797
(0.25%) $92.11
Live Chart Being Loaded With Signals
Omega Diagnostics Group PLC, through its subsidiaries, develops, manufactures, and distributes medical diagnostics products in the United Kingdom, rest of Europe, North America, South/Central America, India, other Asian countries and the Far East, Africa, and the Middle East...
Stats | |
---|---|
Šios dienos apimtis | 59 676.00 |
Vidutinė apimtis | 498 530 |
Rinkos kapitalizacija | 4.94M |
EPS | £0 ( 2023-11-21 ) |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | -2.08 |
ATR14 | £0.204 (11.66%) |
Tūris Koreliacija
Omega Diagnostics Group Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Omega Diagnostics Group Koreliacija - Valiuta/Žaliavos
Omega Diagnostics Group Finansinės ataskaitos
Annual | 2022 |
Pajamos: | £7.55M |
Bruto pelnas: | £3.55M (46.98 %) |
EPS: | £-0.0166 |
FY | 2022 |
Pajamos: | £7.55M |
Bruto pelnas: | £3.55M (46.98 %) |
EPS: | £-0.0166 |
FY | 2022 |
Pajamos: | £8.54M |
Bruto pelnas: | £5.10M (59.75 %) |
EPS: | £-0.00770 |
FY | 2021 |
Pajamos: | £8.73M |
Bruto pelnas: | £4.46M (51.04 %) |
EPS: | £-0.0164 |
Financial Reports:
No articles found.
Omega Diagnostics Group
Omega Diagnostics Group PLC, through its subsidiaries, develops, manufactures, and distributes medical diagnostics products in the United Kingdom, rest of Europe, North America, South/Central America, India, other Asian countries and the Far East, Africa, and the Middle East. The company operates through two segments, Health and Nutrition, and Global Health and Other. The Health and Nutrition segment engages in the research, development, and production of kits to aid the detection of immune reactions to food under the Foodprint name. This segment also provides clinical analysis to the general public, clinics, and health professionals, as well as supplies Food Detective, a consumer food test. The Global Health and Other segment engages in the research, development, production, and marketing of kits that are used in the diagnosis of infectious diseases. This segment offers VISITECT CD4, an advanced disease rapid test, which is used to treat patients with HIV; and AbC-19, a COVID-19 antibody testing kit, as well as COVID-19 antigen and antibody testing solutions. The company offers its products to hospitals, clinics, laboratories, and healthcare practitioners through distributors in approximately 75 countries worldwide. Omega Diagnostics Group PLC was founded in 1987 and is headquartered in Alva, the United Kingdom.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.